Medicines Discovery Catapult (MDC) is enabling the community to reshape medicines discovery in the UK. It is ambitious, and it is achievable.
We do this by championing innovative life science technology and new approaches, supporting UK innovators to succeed.
We are helping to industrialise and drive the adoption of new techniques and technologies.
We are driven by helping our community make their mark on the industry and patients.If you’re involved with medicines discovery in the UK, MDC can almost certainly assist you. Our impact is measured by your success.
Staff and students at the University of Manchester have been recognised for their role in helping to establish the Alderley Park Lighthouse Laboratory in Cheshire,
Investigating new treatment for schizophrenia as first Psychiatry Consortium funded project announced
A partnership between the University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate
Scientists at the Alderley Park Lighthouse Lab in Cheshire have revealed the speed and scale at which the new variant of the COVID virus is